[CEW] From Clinic to Cosmetics: Trendier AI Gives Insights into the Medicosmetics Skin Care Pivot in U.S. and Korea

This article is originally posted on CEW Industry Reports, in collaboration with trendier AI, March 10, 2026 Article. To read the full feature, please visit the link below.

The most significant shift in the 2025 skin care market wasn’t about new textures or sensory experiences. What’s driving the market now is the fact that ingredients derived from medical, pharmaceutical, and regenerative medicine are becoming the central language of everyday skin care.

Medicosmetics isn’t about a specific ingredient trend — it’s a signal that the criteria by which consumers judge skin care are fundamentally changing. Future competitiveness won’t depend on who talks about new ingredients faster, but on who first confirms ingredient diffusion through data and converts it into strategy. 

The question brands need to ask is no longer “which ingredient is trending?” The key is where reactions first appear, how fast they spread, and when they solidify into categories. Trendier AI tracks product counts, brand counts, and review flows over time by ingredient across major global e-commerce channels. 

Ingredients that once belonged exclusively to dermatology clinics or pharmacy channels are now moving into serums and creams, transforming everything from product development to consumer purchase decisions. Korean pharmacy products are becoming must-haves for international tourists, and PDRN and exosomes are transitioning from ‘clinical terminology’ to ‘retail ingredients’ — these aren’t fleeting trends. They signal that consumers are no longer responding to “feel-good products” but to ingredients that evoke mechanism and evidence. 

Trendier AI analyzed cross-market e-commerce data from Olive Young (Korea) and Amazon (U.S.) to identify three ingredient groups that most clearly demonstrate this transformation: 

1. PDRN – a DNA fragment extracted from salmon sperm, first known through dermatology procedures like Rejuran as a medical-based regenerative ingredient. What’s notable is that this ingredient no longer stays confined to clinical settings.
2. Exosomes – 30–150nm extracellular vesicles known in regenerative medicine and bioresearch as ‘bio-messengers.’ In the cosmetics market, exosomes are rapidly establishing themselves as an ingredient group representing high-function imagery like collagen production, damage protection, and skin recovery.
3. Tranexamic Acid (TXA) – originally a pharmaceutical ingredient used for hemostasis but is now rapidly spreading as a global standard solution in the dark spot and pigmentation space.

These represent prime examples of how the medicosmetics movement is expanding across regions.

Download the full report to learn more about medicosmetics and the global expansion of medical-grade ingredients.